JPS59166089A - Ｃｓｆ抑制物質 - Google Patents

Ｃｓｆ抑制物質

Info

Publication number
JPS59166089A
JPS59166089A JP58039146A JP3914683A JPS59166089A JP S59166089 A JPS59166089 A JP S59166089A JP 58039146 A JP58039146 A JP 58039146A JP 3914683 A JP3914683 A JP 3914683A JP S59166089 A JPS59166089 A JP S59166089A
Authority
JP
Japan
Prior art keywords
csf
inhibitory substance
deactivated
stability
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58039146A
Other languages
English (en)
Japanese (ja)
Other versions
JPH056559B2 (online.php
Inventor
Masayoshi Ono
尾野　雅義
Kunitake Hirashima
平嶋　邦猛
Masami Bessho
別所　正美
Ikuo Imazeki
今関　郁夫
Hitoshi Nomura
仁 野村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KAGAKU GIJUTSUCHO HOSHASEN IGAKU SOGO KENKYUSHO
Chugai Pharmaceutical Co Ltd
Original Assignee
KAGAKU GIJUTSUCHO HOSHASEN IGAKU SOGO KENKYUSHO
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KAGAKU GIJUTSUCHO HOSHASEN IGAKU SOGO KENKYUSHO, Chugai Pharmaceutical Co Ltd filed Critical KAGAKU GIJUTSUCHO HOSHASEN IGAKU SOGO KENKYUSHO
Priority to JP58039146A priority Critical patent/JPS59166089A/ja
Priority to EP84102620A priority patent/EP0118908A3/en
Publication of JPS59166089A publication Critical patent/JPS59166089A/ja
Publication of JPH056559B2 publication Critical patent/JPH056559B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP58039146A 1983-03-11 1983-03-11 Ｃｓｆ抑制物質 Granted JPS59166089A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP58039146A JPS59166089A (ja) 1983-03-11 1983-03-11 Ｃｓｆ抑制物質
EP84102620A EP0118908A3 (en) 1983-03-11 1984-03-09 Csf inhibitory substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58039146A JPS59166089A (ja) 1983-03-11 1983-03-11 Ｃｓｆ抑制物質

Publications (2)

Publication Number Publication Date
JPS59166089A true JPS59166089A (ja) 1984-09-19
JPH056559B2 JPH056559B2 (online.php) 1993-01-26

Family

ID=12544964

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58039146A Granted JPS59166089A (ja) 1983-03-11 1983-03-11 Ｃｓｆ抑制物質

Country Status (2)

Country Link
EP (1) EP0118908A3 (online.php)
JP (1) JPS59166089A (online.php)

Also Published As

Publication number Publication date
JPH056559B2 (online.php) 1993-01-26
EP0118908A2 (en) 1984-09-19
EP0118908A3 (en) 1987-05-06

Similar Documents

Publication Publication Date Title
CA1128881A (en) Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells
EP0100982B1 (en) Novel purified plasminogen activator, process for its production and thrombolytic composition containing it
JPS62240700A (ja) ポリペプチド
JP2000053585A (ja) 抗原の精製方法
JPH06107693A (ja) 蛋白質とその蛋白質をコードするｄｎａ並びにその蛋白質の製造方法
EP1105467B9 (en) USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES
JP3805378B2 (ja) ｒＤＳＰＡα１の製造の方法
EP0151996B1 (en) Process for the preparation of a double-chain plasminogen activator
Tamura et al. Purification of human plasma kallikrein and urokinase by affinity chromatography
Polet et al. The influence of three analogs of isoleucine on in vitro growth and protein synthesis of erythrocytic forms of Plasmodium knowlesi
Roberts et al. Isolation and possible relevance of Thermoactinomyces candidus proteinases in farmer's lung disease
CN118440925B (zh) 一种低免疫原性门冬酰胺酶突变体及其制备方法和应用
JPH02149527A (ja) 抗血栓剤
JPH064675B2 (ja) 抗腫瘍性ポリペプチド
JPH056559B2 (online.php)
Nagayama et al. Mouse bone collagenase inhibitor: Purification and partial characterization of the inhibitor from mouse calvaria cultures
JP2859577B2 (ja) 肝実質細胞増殖因子
JPH022390A (ja) 新規なヒト顆粒球マクロファージコロニー刺激因子
CA1206903A (en) Process for the preparation of a plasminogen activator
JP2747355B2 (ja) ヒト血中単球増殖剤
CA1275062A (en) Plasminogen activator kym
RU2326944C2 (ru) Способ получения и препарат аналога рекомбинантного интерферона гамма человека
JPS62205784A (ja) 新しい型のプラスミノ−ゲン活性化因子の製造方法
JPS63190830A (ja) 抗悪性腫瘍剤
Carper et al. Affinity chromatography of glucose dehydrogenase